Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03150836
Title Radiation Therapy and Durvalumab, With or Without Tremelimumab, in Patients With Bladder Cancer
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Terence Friedlander, MD
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.